Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin
Clinical trial NCT00860223 · COMPLETED
Trial details
- NCT number
- NCT00860223
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2009-04-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.